unknown
Stage
2025
Founded
1
Investors
About
CoformerAI accelerates drug development by using AI to pair APIs with coformers, overcoming solubility and bioavailability barriers. The platform employs proprietary molecular mechanism models and robotics to validate solubility gains, enabling partners to advance candidates into small-scale human trials within 12 months.
Explore CoformerAI's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.